✦ LIBER ✦

Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo

✍ Scribed by G A Tipples; M M Ma; K P Fischer; V G Bain; N M Kneteman; D L Tyrrell

Publisher: John Wiley and Sons
Year: 1996
Tongue: English
Weight: 221 KB
Volume: 24
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.510240340

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mutations in hepatitis B DNA polymerase

Mutations in hepatitis B DNA polymerase associated with resistance to lamivudine do not confer resistance to adefovir in vitro

✍ Xiaofeng Xiong; Carmina Flores; Huiling Yang; John J. Toole; Craig S. Gibbs 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 1 views

To determine whether adefovir is active against lamivudine-resistant hepatitis B virus (HBV), the inhibition constants of adefovir diphosphate and lamivudine triphosphate for wild-type and mutant human HBV DNA polymerases, which contain amino acid substitutions associated with lamivudine resistance,

Point mutations in the varicella-zoster

Point mutations in the varicella-zoster virus DNA polymerase gene confers resistance to foscarnet and slow growth phenotype

✍ Visse, Bertrand; Huraux, Jean-Marie; Fillet, Anne-Marie 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 359 KB 👁 1 views

Seven independent laboratory mutants were derived from seven distinct wild-type varicellazoster virus (VZV) isolates after exposure to increasing concentrations of foscarnet (PFA) and were found to be resistant to this drug. Single base changes resulting in amino acid substitutions were observed in

Novel patterns of amino acid mutations i

Novel patterns of amino acid mutations in the hepatitis B virus polymerase in association with resistance to lamivudine therapy in Japanese patients with chronic hepatitis B

✍ Ogata, Norio; Fujii, Kyuichi; Takigawa, Shingo; Nomoto, Minoru; Ichida, Takafumi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB 👁 2 views

Lamivudine is effective in suppressing replication of hepatitis B virus (HBV). However, the emergence of HBV variants resistant to lamivudine is a concern. Lamivudine resistance has been attributed mainly to a substitution of isoleucine or valine for methionine at residue 550 (M550I or M550V) in the

The P140K mutant of human O6-methylguani

The P140K mutant of human O6-methylguanine-DNA-methyltransferase (MGMT) confers resistance in vitro and in vivo to temozolomide in combination with the novel MGMT inactivator O6-(4-bromothenyl)guanine

✍ Lorna B. Woolford; Thomas D. Southgate; Geoffrey P. Margison; Michael D. Milsom; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB

The O 6 -methylguanine-DNA-methyltransferase (MGMT) inactivator O 6benzylguanine (O 6 -beG) is currently under clinical investigation as a potential tumour-sensitising agent. In clinical trials its use has been associated with increased myelotoxicity and a reduced maximum tolerated dose (MTD) for BC